Contineum Therapeutics’ M1 receptor antagonist has failed to move the needle in a phase 2 vision test for patients with a common form of multiple sclerosis. | Contineum Therapeutics’ M1 receptor ...
Vision changes with SPMS can involve slow visual processing and motion sensitivity, but it’s possible to manage them.
A wireless implant helped patients with severe macular degeneration regain usable vision. The results point toward a new ...
Medical services include women's health exams, primary care exams, vision screenings, hearing screenings (Saturday only), ...
Without adopting Canberra's policies wholesale, the UK's intelligence-policymaker network would benefit from making some of ...
Apple’s Senior Vice President Eddy Cue—one of the most influential figures in the global tech and entertainment ...
The investment will expand clean, connected, and accessible mobility through the Cumberland Autonomous Mobility Network across Georgia's economic ...
The university is upgrading its athletic facilities as it prepares to join the Mountain West Conference next year.
Athian has paid dairy farmers $18 million since 2024 for emissions-reducing practices, linking on-farm improvements with food ...
Visionstate Corp. (TSXV: VIS) (“Visionstate” or the “Company”), is pleased to highlight the progress of its artificial intelligence ...
“Artificial intelligence is becoming the defining the defining trend of our time, said Hover Gao, President of Huawei ...
In a federally funded study, Mass General Brigham investigators found self-reported vision problems and traumatic stress are experienced years after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback